Kathryn E. Stephenson

Author

Beth Israel Deaconess Medical Center ORCID

Also Known As

Beverly Ewing, Carolene Stephenson, Fischer, Rebecca S. B., Gelderblom, Huub C., Johan Lombaard, K Stephenson, K. Stephenson, Kathryn E. Stephenson, Kathryn E Stephenson, Kathryn E. Stephenson

102

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Ragon Institute of MGH, MIT and Harvard Harvard University Janssen (Netherlands)Massachusetts General Hospital

About

Kathryn E. Stephenson is an author at Beth Israel Deaconess Medical Center specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	2.6K
2	Immunology	16	16	2K
3	Epidemiology	4	4	305
4	Public Health	1	1	50
5	Health Policy	1	1	50

Kathryn E. Stephenson

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev, New England Journal of Medicine	2021	1.2K
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys Dan H. Barouch, James B. Whitney, Brian Moldt, Nature	2013	628
Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys Peter Abbink, Rafael A. Larocca, Rafael A. De La Barrera, Science VaccinationVaccine SafetyProtective EfficacyVaccine DevelopmentPlasmid Dna Vaccine	2016	500
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans Galit Alter, Jingyou Yu, Jinyan Liu, Nature	2021	342
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys Dan H. Barouch, Kathryn E. Stephenson, Erica N. Borducchi, Cell VaccinationProtective EfficacyVaccine DevelopmentHeterologous Shiv ChallengesRhesus Monkeys	2013	337
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19) Dan H. Barouch, Frank Tomaka, Frank Wegmann, The Lancet VaccinationVaccine DevelopmentNhp 13-19Rhesus MonkeysImmunology	2018	334
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19 Kathryn E. Stephenson, Mathieu Le Gars, Jerald Sadoff, JAMA	2021	313
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys Erica N. Borducchi, Crystal Cabral, Kathryn E. Stephenson, Nature VaccinationTlr7 StimulationMucosal VaccinationVaccine DevelopmentVaccine Target	2016	267
Vascular Disease and Thrombosis in SARS-CoV-2-Infected Rhesus Macaques Malika Aïd, Kathleen Busman‐Sahay, Samuel J. Vidal, Cell ThrombosisVascular DiseaseViral PersistenceViral PathogenesisVirology	2020	221
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting Boris Jülg, Lynda Dee, Jintanat Ananworanich, The Lancet HIV Treatment And PreventionConsensus MeetingClinical TrialsHiv Research Trials—reportAntiviral Therapy	2019	198

Page 1